• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AV1
Click for more information
1.33% 7.6¢

ADVERITAS LIMITED - News & Media

Market Cap $59.15M  ! watchlist Created with Sketch. Add to my watchlist
Technology Software - Application

Adveritas Limited is an Australia-based company, which creates software solutions that... Adveritas Limited is an Australia-based company, which creates software solutions that leverage big data to drive business performance. Its segments include Product and Engineering, Sales and marketing and Corporate. The Product and Engineering segment is engaged in the development and maintenance of the Company’s proprietary software offerings. These activities are conducted in Australia and Croatia. The Sales and marketing segment is engaged in deploying its sales and marketing initiatives and for providing ongoing customer service. These activities are carried out by sales and marketing personnel and consultants located in the Australia Pacific region, Europe and South-east Asia. Its ad fraud prevention software, TrafficGuard, is its available software as a service. TrafficGuard is a full funnel measurement, verification and fraud prevention solution for digital advertising. TrafficGuard detects, mitigates and reports on ad fraud before it impacts digital advertising budgets.More

Articles & Videos

Adveritas (ASX:AV1) posts record quarterly cash receipts, launches $4m placement

Adveritas (ASX:AV1) has posted record cash receipts of $887,000 over the December 2022 quarter — a 36 per cent increase compared to the same quarter the year before.

30 Jan 2023 18:30 (AEDT)



(20min delay)
Last
7.6¢ 		Change
0.001(1.33%) 		Mkt cap ! $59.15M
Open High Low Value Volume
7.6¢ 7.6¢ 7.6¢ $1.596K 21K

Buyers (Bids)

No. Vol. Price($)
2 244549 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 27856 1
View Market Depth
Last trade - 10.22am 02/10/2024 (20 minute delay) ?
AV1 (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Firebird achieves preliminary approvals for its Jinshi plant design Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.